Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY | - | Yearly | 90+0 | - | 8 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Committee Course |
| Course Coordinator | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Name of Lecturer(s) | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Assistant(s) | |
| Aim | To evaluate the general pharmacology subjects and the pharmacological properties of drugs that affect body systems. |
| Course Content | This course contains; Drugs Used in the Treatment of Anemia,Antiviral drugs,Immunomodulator Drugs,Pharmacological Principles of Cancer Treatment,Antineoplastic Drugs,Toxic Effects of Drugs and Basic Concepts of Toxicology,Antihypertensive Drugs,Pharmacological Aspects of Autonomic Nervous System,Anticoagulant Drugs,Antiplatelet and Fibrinolytic Drugs,Beta-Adrenergic Receptor Blockers,Drugs Used in the Treatment of Angina Pectoris,Parasympathomimetic and Anticholinesterase Drugs,Parasympatholytic Drugs,Sympathomimetic Drugs,Sympatholytic drugs,Nicotine, Ganglion Stimulants, Ganglion Blockers,Drugs Used in Water and Electrolyte Balance Disorders,Acid-Base Balance Disorders,Peripheral Vasodilators,Drugs Used in Heart Failure: Heart Glycosides,Other Drugs Used in Heart Failure,Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume,Hypolipidemic Drugs,Drugs Used in Cardiac Dermatitis,Antihistaminic Drugs,Cough Treatment and Drugs Used in Colds,Bronchodilator Drugs,Antitussive Drugs, Expectorants and Mucolytics,Vitamins,Oxygen, Ozone and Other Treatment Gases,Introduction to Clinical Pharmacology-Lower and Side Branches,Pharmaceutical Forms of Drugs,Drug Application Paths,Transition and Absorption of Drugs from Membranes,Distribution of drugs,Biotransformation of drugs,Excretion of Drugs,Factors that change the effect of drugs,Pharmacogenetics,Pharmacokinetic Interactions Between Drugs,eceptors and Drug Receptor Interaction,Dose-Concentration-Effect Relationship,Mechanisms of Drugs,Otachoids (Eicosanoids-Prostaglandins And Other Otakoids),tachoids (Histamine),Otachoids (Serotonin And Serotonin Agonist And Antagonists),Peptide Structured Otachoids And Nitric Oxide,General Properties of Antimicrobial Chemotherapeutics,Penicillins, Beta-Lactamase Inhibitors,Cephalosporins,Other Beta-Lactam Antibiotics,Antimycobacterial Drugs,Narrow Spectrum Antistafilokokal And Antianaerobic Drugs,Aminoglycosides,Sulfonamides, Co-Trimoxazole, Trimethoprim,Amfenicols, Tetracyclines,Fluoroquinolones,Macrolides,Thyroid Hormones and Antithyroid Drugs,Drugs Affecting Bone Mineral Homeostasis,Insulin, Oral Antidiabetic Drugs and Glucagon,Corticosteroids, Antagonists and ACTH,Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides,Anti-Malarial Drugs,Antihelmintik Drugs,Ectoparasitic Drugs,Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs,Traditional and Complementary Medicine Applications,Digestive Auxiliary Drugs and Antidiarrheals,Drugs Used in Peptic Ulcer Treatment,Laxatives and Purgatives,Pharmacovigilance,Emetic, Antiemetic and Prokinetic Drugs,Androgens, Anabolic Steroids and Antiandrogenic Drugs,Female Gender Hormones,Oxytocic Drugs,Contraceptive drugs,Diuretics,Drugs Specific to the Treatment of Urinary Infections,Drug Innovation - Introduction to Clinical Pharmacology,Principles of Rational Drug Use,Fundamentals of Central Nervous System Pharmacology,Drugs Used in Dementia Treatment,Neuroleptic Drugs (Antipsychotic Drugs),Antidepressant and Antimanic Drugs,Pharmacology of General Anesthesia and General Anesthetics,Central Nervous System Situmulants and Hallucinogens,Narcotic (Opioid) Analgesics,Antiepileptic Drugs,Drug Abuse and Addiction,Hypnotics,Alcohols,Drugs Used in Headache,Drugs Used in Dementia Treatment,Antiparkinson Drugs,Non-Steroidal Anti-Inflammatory Drugs,Acetaminophen,Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers,Local Anesthetic Drugs,Prescription Information,Drugs Used in Gout Treatment. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. evaluate the basic subjects of the pharmacology. 1.1. identify the functions of the drug pharmacokinetics and pharmacodynamics. 1.2. explain the functions of drug pharmacokinetics and pharmacodynamics. 1.3. summarize the drugs pharmacokinetics and pharmacodynamics. | 10, 13, 16, 19, 4, 9 | A |
| 2. evaluate the drug toxicity and addiction. 2.1. identify the drug toxicity and abuse. 2.2. explain the drug toxicity and their mechanism. 2.3. give examples of drug toxicity, and drug abuse. | 10, 13, 16, 19, 4, 9 | A |
| 3. evaluate the central nervous stystem (CNS) drugs. 3.1. identify the pharmacokinetics and pharmacodynamics of CNS drugs. 3.2. explain the functions such as pharmacokinetics and pharmacodynamics of CNS drugs. 3.3. give examples of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| 4. evaluate the analgesics, anti-inflammatories and anesthetics. 4.1. identify the characteristics such as pharmacokinetics and pharmacodynamics of the analgesic, anti-inflammatory and anesthetic drugs. 4.2. interpret the mechanisms of analgesic, anti-inflammatory and anesthetic drugs action. 4.3. give examples of analgesic, anti-inflammatory and anesthetic drugs. | 10, 13, 16, 19, 4, 9 | A |
| 5. explain pharmacokinetics and pharmacodynamics of autonom drugs. They can also discuss their advers effect profiles and drug interactions. 5.1. summarize the pharmacokinetics, pharmacodynamics, adverse effects, contraindications and drug interactions of the autonom drugs. 5.2. interpret the mechanisms of autonom drugs. 5.3. give examples of autonomic drugs. | 10, 13, 16, 19, 4, 9 | A |
| 6. explain the pharmacokinetics and pharmacodynamics of endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. They can also discuss their advers effect profiles and drug interactions. 6.1. summarize the pharmacokinetic, pharmacodynamics, adverse effects, contraindications and drug interactions of the endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. 6.2. interpret the mechanisms of endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. 6.3. give examples of endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. | 10, 13, 16, 19, 4, 9 | A |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 4: Inquiry-Based Learning, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Drugs Used in the Treatment of Anemia | |
| 2 | Antiviral drugs | |
| 3 | Immunomodulator Drugs | |
| 4 | Pharmacological Principles of Cancer Treatment | |
| 5 | Antineoplastic Drugs | |
| 6 | Toxic Effects of Drugs and Basic Concepts of Toxicology | |
| 7 | Antihypertensive Drugs | |
| 8 | Pharmacological Aspects of Autonomic Nervous System | |
| 9 | Anticoagulant Drugs | |
| 10 | Antiplatelet and Fibrinolytic Drugs | |
| 11 | Beta-Adrenergic Receptor Blockers | |
| 12 | Drugs Used in the Treatment of Angina Pectoris | |
| 13 | Parasympathomimetic and Anticholinesterase Drugs | |
| 14 | Parasympatholytic Drugs | |
| 15 | Sympathomimetic Drugs | |
| 16 | Sympatholytic drugs | |
| 17 | Nicotine, Ganglion Stimulants, Ganglion Blockers | |
| 18 | Drugs Used in Water and Electrolyte Balance Disorders | |
| 19 | Acid-Base Balance Disorders | |
| 20 | Peripheral Vasodilators | |
| 21 | Drugs Used in Heart Failure: Heart Glycosides | |
| 22 | Other Drugs Used in Heart Failure | |
| 23 | Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume | |
| 24 | Hypolipidemic Drugs | |
| 25 | Drugs Used in Cardiac Dermatitis | |
| 26 | Antihistaminic Drugs | |
| 27 | Cough Treatment and Drugs Used in Colds | |
| 28 | Bronchodilator Drugs | |
| 29 | Antitussive Drugs, Expectorants and Mucolytics | |
| 30 | Vitamins | |
| 31 | Oxygen, Ozone and Other Treatment Gases | |
| 32 | Introduction to Clinical Pharmacology-Lower and Side Branches | |
| 33 | Pharmaceutical Forms of Drugs | |
| 34 | Drug Application Paths | |
| 35 | Transition and Absorption of Drugs from Membranes | |
| 36 | Distribution of drugs | |
| 37 | Biotransformation of drugs | |
| 38 | Excretion of Drugs | |
| 39 | Factors that change the effect of drugs | |
| 40 | Pharmacogenetics | |
| 41 | Pharmacokinetic Interactions Between Drugs | |
| 42 | eceptors and Drug Receptor Interaction | |
| 43 | Dose-Concentration-Effect Relationship | |
| 44 | Mechanisms of Drugs | |
| 45 | Otachoids (Eicosanoids-Prostaglandins And Other Otakoids) | |
| 46 | tachoids (Histamine) | |
| 47 | Otachoids (Serotonin And Serotonin Agonist And Antagonists) | |
| 48 | Peptide Structured Otachoids And Nitric Oxide | |
| 49 | General Properties of Antimicrobial Chemotherapeutics | |
| 50 | Penicillins, Beta-Lactamase Inhibitors | |
| 51 | Cephalosporins | |
| 52 | Other Beta-Lactam Antibiotics | |
| 53 | Antimycobacterial Drugs | |
| 54 | Narrow Spectrum Antistafilokokal And Antianaerobic Drugs | |
| 55 | Aminoglycosides | |
| 56 | Sulfonamides, Co-Trimoxazole, Trimethoprim | |
| 57 | Amfenicols, Tetracyclines | |
| 58 | Fluoroquinolones | |
| 59 | Macrolides | |
| 60 | Thyroid Hormones and Antithyroid Drugs | |
| 61 | Drugs Affecting Bone Mineral Homeostasis | |
| 62 | Insulin, Oral Antidiabetic Drugs and Glucagon | |
| 63 | Corticosteroids, Antagonists and ACTH | |
| 64 | Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides | |
| 65 | Anti-Malarial Drugs | |
| 66 | Antihelmintik Drugs | |
| 67 | Ectoparasitic Drugs | |
| 68 | Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs | |
| 69 | Traditional and Complementary Medicine Applications | |
| 70 | Digestive Auxiliary Drugs and Antidiarrheals | |
| 71 | Drugs Used in Peptic Ulcer Treatment | |
| 72 | Laxatives and Purgatives | |
| 73 | Pharmacovigilance | |
| 74 | Emetic, Antiemetic and Prokinetic Drugs | |
| 75 | Androgens, Anabolic Steroids and Antiandrogenic Drugs | |
| 76 | Female Gender Hormones | |
| 77 | Oxytocic Drugs | |
| 78 | Contraceptive drugs | |
| 79 | Diuretics | |
| 80 | Drugs Specific to the Treatment of Urinary Infections | |
| 81 | Drug Innovation - Introduction to Clinical Pharmacology | |
| 82 | Principles of Rational Drug Use | |
| 83 | Fundamentals of Central Nervous System Pharmacology | |
| 84 | Drugs Used in Dementia Treatment | |
| 85 | Neuroleptic Drugs (Antipsychotic Drugs) | |
| 86 | Antidepressant and Antimanic Drugs | |
| 87 | Pharmacology of General Anesthesia and General Anesthetics | |
| 88 | Central Nervous System Situmulants and Hallucinogens | |
| 89 | Narcotic (Opioid) Analgesics | |
| 90 | Antiepileptic Drugs | |
| 91 | Drug Abuse and Addiction | |
| 92 | Hypnotics | |
| 93 | Alcohols | |
| 94 | Drugs Used in Headache | |
| 95 | Drugs Used in Dementia Treatment | |
| 96 | Antiparkinson Drugs | |
| 97 | Non-Steroidal Anti-Inflammatory Drugs | |
| 98 | Acetaminophen | |
| 99 | Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers | |
| 100 | Local Anesthetic Drugs | |
| 101 | Prescription Information | |
| 102 | Drugs Used in Gout Treatment |
| Resources |
| Pharmacology notes wil be given to the students. |
| 1. Kayaalp, SO: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, Ankara. 2. Hardman JG, Limbird LE, Eds.: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York. 3. Katzung & Trevor: Farmakoloji, Ankara. |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | Knows structural (morphological) and operational (functional) properties of the normal human (medical) and disorder (disease) states | X | |||||
| 2 | Knows diagnostic methods and treatment modalities of disorders (diseases). | X | |||||
| 3 | Knows the causes of disease conditions, ways of protection and methods of promoting and improving community health. | X | |||||
| 4 | Knows the methods of developing and applying health related knowledge at advanced level. | X | |||||
| 5 | Able to reach multidisciplinary advanced knowledge regarding health-related disciplines, interpret and apply the knowledge. | X | |||||
| 6 | Performs a complete clinical examination of human body structurally and functionally and identifies problems. | X | |||||
| 7 | Interprets laboratory results for diagnosis, compares with clinical data and develop solution proposals. | X | |||||
| 8 | Selects and implements appropriate tools for the promotion and development of individual and community health. | X | |||||
| 9 | Plans and conducts an advanced study on health independently. | X | |||||
| 10 | Develops new strategic approaches to solve the problems encountered in the promotion and development of individual and community health. | X | |||||
| 11 | Takes the responsibility of any type of practice when diagnosing and treating human body | X | |||||
| 12 | Takes the role as a leader or a team worker when solving health related problems. | X | |||||
| 13 | Evaluates knowledge and skills regarding health with a critical approach and develops a positive attitude towards lifelong learning. | X | |||||
| 14 | Informs the patient, related people, institutions and the society about the health problems and transfers solution proposals in writing, verbally and visually using effective communication means. | X | |||||
| 15 | Critically reviews, develops and acts on changes in social relations and norms that guide such relationships. | X | |||||
| 16 | Uses English at least at the European Language Portfolio B2 Level, monitors knowledge and communicates in his field. | X | |||||
| 17 | Able to use advanced computer skills and informatics and communication technologies at a level required by the field. | X | |||||
| 18 | Acquires, interprets, implements and announces data related to the health and acts in accordance with social, scientific, cultural and ethical values and teaches these values. | X | |||||
| 19 | Develops strategies, policy and implementation plans in the field of health and evaluates the results obtained within the framework of quality processes. | X | |||||
| 20 | Shares studies on the promotion and development of health with interdisciplinary specialists systematically, supporting with quantitative and qualitative data. | ||||||
| 21 | Has adequate awareness on occupational health and safety issues. | ||||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |
| ECTS / Workload Table | ||||||
| Activities | Number of | Duration(Hour) | Total Workload(Hour) | |||
| Course Hours | 0 | 0 | 0 | |||
| Guided Problem Solving | 0 | 0 | 0 | |||
| Resolution of Homework Problems and Submission as a Report | 0 | 0 | 0 | |||
| Term Project | 0 | 0 | 0 | |||
| Presentation of Project / Seminar | 0 | 0 | 0 | |||
| Quiz | 0 | 0 | 0 | |||
| Midterm Exam | 0 | 0 | 0 | |||
| General Exam | 0 | 0 | 0 | |||
| Performance Task, Maintenance Plan | 0 | 0 | 0 | |||
| Total Workload(Hour) | 0 | |||||
| Dersin AKTS Kredisi = Toplam İş Yükü (Saat)/30*=(0/30) | 0 | |||||
| ECTS of the course: 30 hours of work is counted as 1 ECTS credit. | ||||||
Detail Informations of the Course
Course Description
| Course | Code | Semester | T+P (Hour) | Credit | ECTS |
|---|---|---|---|---|---|
| PHARMACOLOGY | - | Yearly | 90+0 | - | 8 |
| Course Program |
| Prerequisites Courses | |
| Recommended Elective Courses |
| Language of Course | Turkish |
| Course Level | First Cycle (Bachelor's Degree) |
| Course Type | Committee Course |
| Course Coordinator | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Name of Lecturer(s) | Assoc.Prof. Ayşe Arzu ŞAKUL |
| Assistant(s) | |
| Aim | To evaluate the general pharmacology subjects and the pharmacological properties of drugs that affect body systems. |
| Course Content | This course contains; Drugs Used in the Treatment of Anemia,Antiviral drugs,Immunomodulator Drugs,Pharmacological Principles of Cancer Treatment,Antineoplastic Drugs,Toxic Effects of Drugs and Basic Concepts of Toxicology,Antihypertensive Drugs,Pharmacological Aspects of Autonomic Nervous System,Anticoagulant Drugs,Antiplatelet and Fibrinolytic Drugs,Beta-Adrenergic Receptor Blockers,Drugs Used in the Treatment of Angina Pectoris,Parasympathomimetic and Anticholinesterase Drugs,Parasympatholytic Drugs,Sympathomimetic Drugs,Sympatholytic drugs,Nicotine, Ganglion Stimulants, Ganglion Blockers,Drugs Used in Water and Electrolyte Balance Disorders,Acid-Base Balance Disorders,Peripheral Vasodilators,Drugs Used in Heart Failure: Heart Glycosides,Other Drugs Used in Heart Failure,Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume,Hypolipidemic Drugs,Drugs Used in Cardiac Dermatitis,Antihistaminic Drugs,Cough Treatment and Drugs Used in Colds,Bronchodilator Drugs,Antitussive Drugs, Expectorants and Mucolytics,Vitamins,Oxygen, Ozone and Other Treatment Gases,Introduction to Clinical Pharmacology-Lower and Side Branches,Pharmaceutical Forms of Drugs,Drug Application Paths,Transition and Absorption of Drugs from Membranes,Distribution of drugs,Biotransformation of drugs,Excretion of Drugs,Factors that change the effect of drugs,Pharmacogenetics,Pharmacokinetic Interactions Between Drugs,eceptors and Drug Receptor Interaction,Dose-Concentration-Effect Relationship,Mechanisms of Drugs,Otachoids (Eicosanoids-Prostaglandins And Other Otakoids),tachoids (Histamine),Otachoids (Serotonin And Serotonin Agonist And Antagonists),Peptide Structured Otachoids And Nitric Oxide,General Properties of Antimicrobial Chemotherapeutics,Penicillins, Beta-Lactamase Inhibitors,Cephalosporins,Other Beta-Lactam Antibiotics,Antimycobacterial Drugs,Narrow Spectrum Antistafilokokal And Antianaerobic Drugs,Aminoglycosides,Sulfonamides, Co-Trimoxazole, Trimethoprim,Amfenicols, Tetracyclines,Fluoroquinolones,Macrolides,Thyroid Hormones and Antithyroid Drugs,Drugs Affecting Bone Mineral Homeostasis,Insulin, Oral Antidiabetic Drugs and Glucagon,Corticosteroids, Antagonists and ACTH,Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides,Anti-Malarial Drugs,Antihelmintik Drugs,Ectoparasitic Drugs,Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs,Traditional and Complementary Medicine Applications,Digestive Auxiliary Drugs and Antidiarrheals,Drugs Used in Peptic Ulcer Treatment,Laxatives and Purgatives,Pharmacovigilance,Emetic, Antiemetic and Prokinetic Drugs,Androgens, Anabolic Steroids and Antiandrogenic Drugs,Female Gender Hormones,Oxytocic Drugs,Contraceptive drugs,Diuretics,Drugs Specific to the Treatment of Urinary Infections,Drug Innovation - Introduction to Clinical Pharmacology,Principles of Rational Drug Use,Fundamentals of Central Nervous System Pharmacology,Drugs Used in Dementia Treatment,Neuroleptic Drugs (Antipsychotic Drugs),Antidepressant and Antimanic Drugs,Pharmacology of General Anesthesia and General Anesthetics,Central Nervous System Situmulants and Hallucinogens,Narcotic (Opioid) Analgesics,Antiepileptic Drugs,Drug Abuse and Addiction,Hypnotics,Alcohols,Drugs Used in Headache,Drugs Used in Dementia Treatment,Antiparkinson Drugs,Non-Steroidal Anti-Inflammatory Drugs,Acetaminophen,Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers,Local Anesthetic Drugs,Prescription Information,Drugs Used in Gout Treatment. |
| Dersin Öğrenme Kazanımları | Teaching Methods | Assessment Methods |
| 1. evaluate the basic subjects of the pharmacology. 1.1. identify the functions of the drug pharmacokinetics and pharmacodynamics. 1.2. explain the functions of drug pharmacokinetics and pharmacodynamics. 1.3. summarize the drugs pharmacokinetics and pharmacodynamics. | 10, 13, 16, 19, 4, 9 | A |
| 2. evaluate the drug toxicity and addiction. 2.1. identify the drug toxicity and abuse. 2.2. explain the drug toxicity and their mechanism. 2.3. give examples of drug toxicity, and drug abuse. | 10, 13, 16, 19, 4, 9 | A |
| 3. evaluate the central nervous stystem (CNS) drugs. 3.1. identify the pharmacokinetics and pharmacodynamics of CNS drugs. 3.2. explain the functions such as pharmacokinetics and pharmacodynamics of CNS drugs. 3.3. give examples of CNS drugs. | 10, 13, 16, 19, 4, 9 | A |
| 4. evaluate the analgesics, anti-inflammatories and anesthetics. 4.1. identify the characteristics such as pharmacokinetics and pharmacodynamics of the analgesic, anti-inflammatory and anesthetic drugs. 4.2. interpret the mechanisms of analgesic, anti-inflammatory and anesthetic drugs action. 4.3. give examples of analgesic, anti-inflammatory and anesthetic drugs. | 10, 13, 16, 19, 4, 9 | A |
| 5. explain pharmacokinetics and pharmacodynamics of autonom drugs. They can also discuss their advers effect profiles and drug interactions. 5.1. summarize the pharmacokinetics, pharmacodynamics, adverse effects, contraindications and drug interactions of the autonom drugs. 5.2. interpret the mechanisms of autonom drugs. 5.3. give examples of autonomic drugs. | 10, 13, 16, 19, 4, 9 | A |
| 6. explain the pharmacokinetics and pharmacodynamics of endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. They can also discuss their advers effect profiles and drug interactions. 6.1. summarize the pharmacokinetic, pharmacodynamics, adverse effects, contraindications and drug interactions of the endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. 6.2. interpret the mechanisms of endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. 6.3. give examples of endocrin, cardiovascular, respiratuar and gastrointestinal system drugs. | 10, 13, 16, 19, 4, 9 | A |
| Teaching Methods: | 10: Discussion Method, 13: Case Study Method, 16: Question - Answer Technique, 19: Brainstorming Technique, 4: Inquiry-Based Learning, 9: Lecture Method |
| Assessment Methods: | A: Traditional Written Exam |
Course Outline
| Order | Subjects | Preliminary Work |
|---|---|---|
| 1 | Drugs Used in the Treatment of Anemia | |
| 2 | Antiviral drugs | |
| 3 | Immunomodulator Drugs | |
| 4 | Pharmacological Principles of Cancer Treatment | |
| 5 | Antineoplastic Drugs | |
| 6 | Toxic Effects of Drugs and Basic Concepts of Toxicology | |
| 7 | Antihypertensive Drugs | |
| 8 | Pharmacological Aspects of Autonomic Nervous System | |
| 9 | Anticoagulant Drugs | |
| 10 | Antiplatelet and Fibrinolytic Drugs | |
| 11 | Beta-Adrenergic Receptor Blockers | |
| 12 | Drugs Used in the Treatment of Angina Pectoris | |
| 13 | Parasympathomimetic and Anticholinesterase Drugs | |
| 14 | Parasympatholytic Drugs | |
| 15 | Sympathomimetic Drugs | |
| 16 | Sympatholytic drugs | |
| 17 | Nicotine, Ganglion Stimulants, Ganglion Blockers | |
| 18 | Drugs Used in Water and Electrolyte Balance Disorders | |
| 19 | Acid-Base Balance Disorders | |
| 20 | Peripheral Vasodilators | |
| 21 | Drugs Used in Heart Failure: Heart Glycosides | |
| 22 | Other Drugs Used in Heart Failure | |
| 23 | Hemostatic Drugs and Hemostatic Blood Products, Solutions Expanding Plasma Volume | |
| 24 | Hypolipidemic Drugs | |
| 25 | Drugs Used in Cardiac Dermatitis | |
| 26 | Antihistaminic Drugs | |
| 27 | Cough Treatment and Drugs Used in Colds | |
| 28 | Bronchodilator Drugs | |
| 29 | Antitussive Drugs, Expectorants and Mucolytics | |
| 30 | Vitamins | |
| 31 | Oxygen, Ozone and Other Treatment Gases | |
| 32 | Introduction to Clinical Pharmacology-Lower and Side Branches | |
| 33 | Pharmaceutical Forms of Drugs | |
| 34 | Drug Application Paths | |
| 35 | Transition and Absorption of Drugs from Membranes | |
| 36 | Distribution of drugs | |
| 37 | Biotransformation of drugs | |
| 38 | Excretion of Drugs | |
| 39 | Factors that change the effect of drugs | |
| 40 | Pharmacogenetics | |
| 41 | Pharmacokinetic Interactions Between Drugs | |
| 42 | eceptors and Drug Receptor Interaction | |
| 43 | Dose-Concentration-Effect Relationship | |
| 44 | Mechanisms of Drugs | |
| 45 | Otachoids (Eicosanoids-Prostaglandins And Other Otakoids) | |
| 46 | tachoids (Histamine) | |
| 47 | Otachoids (Serotonin And Serotonin Agonist And Antagonists) | |
| 48 | Peptide Structured Otachoids And Nitric Oxide | |
| 49 | General Properties of Antimicrobial Chemotherapeutics | |
| 50 | Penicillins, Beta-Lactamase Inhibitors | |
| 51 | Cephalosporins | |
| 52 | Other Beta-Lactam Antibiotics | |
| 53 | Antimycobacterial Drugs | |
| 54 | Narrow Spectrum Antistafilokokal And Antianaerobic Drugs | |
| 55 | Aminoglycosides | |
| 56 | Sulfonamides, Co-Trimoxazole, Trimethoprim | |
| 57 | Amfenicols, Tetracyclines | |
| 58 | Fluoroquinolones | |
| 59 | Macrolides | |
| 60 | Thyroid Hormones and Antithyroid Drugs | |
| 61 | Drugs Affecting Bone Mineral Homeostasis | |
| 62 | Insulin, Oral Antidiabetic Drugs and Glucagon | |
| 63 | Corticosteroids, Antagonists and ACTH | |
| 64 | Antifungal Antibiotics and Other Antifungal Drugs and Linkozamides | |
| 65 | Anti-Malarial Drugs | |
| 66 | Antihelmintik Drugs | |
| 67 | Ectoparasitic Drugs | |
| 68 | Interactions Between Antimicrobial Drugs and Combinations, Antiprotozoal Drugs | |
| 69 | Traditional and Complementary Medicine Applications | |
| 70 | Digestive Auxiliary Drugs and Antidiarrheals | |
| 71 | Drugs Used in Peptic Ulcer Treatment | |
| 72 | Laxatives and Purgatives | |
| 73 | Pharmacovigilance | |
| 74 | Emetic, Antiemetic and Prokinetic Drugs | |
| 75 | Androgens, Anabolic Steroids and Antiandrogenic Drugs | |
| 76 | Female Gender Hormones | |
| 77 | Oxytocic Drugs | |
| 78 | Contraceptive drugs | |
| 79 | Diuretics | |
| 80 | Drugs Specific to the Treatment of Urinary Infections | |
| 81 | Drug Innovation - Introduction to Clinical Pharmacology | |
| 82 | Principles of Rational Drug Use | |
| 83 | Fundamentals of Central Nervous System Pharmacology | |
| 84 | Drugs Used in Dementia Treatment | |
| 85 | Neuroleptic Drugs (Antipsychotic Drugs) | |
| 86 | Antidepressant and Antimanic Drugs | |
| 87 | Pharmacology of General Anesthesia and General Anesthetics | |
| 88 | Central Nervous System Situmulants and Hallucinogens | |
| 89 | Narcotic (Opioid) Analgesics | |
| 90 | Antiepileptic Drugs | |
| 91 | Drug Abuse and Addiction | |
| 92 | Hypnotics | |
| 93 | Alcohols | |
| 94 | Drugs Used in Headache | |
| 95 | Drugs Used in Dementia Treatment | |
| 96 | Antiparkinson Drugs | |
| 97 | Non-Steroidal Anti-Inflammatory Drugs | |
| 98 | Acetaminophen | |
| 99 | Neuromuscular Blocking Drugs, Central Effective Muscle Relaxers | |
| 100 | Local Anesthetic Drugs | |
| 101 | Prescription Information | |
| 102 | Drugs Used in Gout Treatment |
| Resources |
| Pharmacology notes wil be given to the students. |
| 1. Kayaalp, SO: Rasyonel Tedavi Yönünden Tıbbi Farmakoloji, Ankara. 2. Hardman JG, Limbird LE, Eds.: Goodman and Gilman’s The Pharmacological Basis of Therapeutics, New York. 3. Katzung & Trevor: Farmakoloji, Ankara. |
Course Contribution to Program Qualifications
| Course Contribution to Program Qualifications | |||||||
| No | Program Qualification | Contribution Level | |||||
| 1 | 2 | 3 | 4 | 5 | |||
| 1 | Knows structural (morphological) and operational (functional) properties of the normal human (medical) and disorder (disease) states | X | |||||
| 2 | Knows diagnostic methods and treatment modalities of disorders (diseases). | X | |||||
| 3 | Knows the causes of disease conditions, ways of protection and methods of promoting and improving community health. | X | |||||
| 4 | Knows the methods of developing and applying health related knowledge at advanced level. | X | |||||
| 5 | Able to reach multidisciplinary advanced knowledge regarding health-related disciplines, interpret and apply the knowledge. | X | |||||
| 6 | Performs a complete clinical examination of human body structurally and functionally and identifies problems. | X | |||||
| 7 | Interprets laboratory results for diagnosis, compares with clinical data and develop solution proposals. | X | |||||
| 8 | Selects and implements appropriate tools for the promotion and development of individual and community health. | X | |||||
| 9 | Plans and conducts an advanced study on health independently. | X | |||||
| 10 | Develops new strategic approaches to solve the problems encountered in the promotion and development of individual and community health. | X | |||||
| 11 | Takes the responsibility of any type of practice when diagnosing and treating human body | X | |||||
| 12 | Takes the role as a leader or a team worker when solving health related problems. | X | |||||
| 13 | Evaluates knowledge and skills regarding health with a critical approach and develops a positive attitude towards lifelong learning. | X | |||||
| 14 | Informs the patient, related people, institutions and the society about the health problems and transfers solution proposals in writing, verbally and visually using effective communication means. | X | |||||
| 15 | Critically reviews, develops and acts on changes in social relations and norms that guide such relationships. | X | |||||
| 16 | Uses English at least at the European Language Portfolio B2 Level, monitors knowledge and communicates in his field. | X | |||||
| 17 | Able to use advanced computer skills and informatics and communication technologies at a level required by the field. | X | |||||
| 18 | Acquires, interprets, implements and announces data related to the health and acts in accordance with social, scientific, cultural and ethical values and teaches these values. | X | |||||
| 19 | Develops strategies, policy and implementation plans in the field of health and evaluates the results obtained within the framework of quality processes. | X | |||||
| 20 | Shares studies on the promotion and development of health with interdisciplinary specialists systematically, supporting with quantitative and qualitative data. | ||||||
| 21 | Has adequate awareness on occupational health and safety issues. | ||||||
Assessment Methods
| Contribution Level | Absolute Evaluation | |
| Rate of Midterm Exam to Success | 40 | |
| Rate of Final Exam to Success | 60 | |
| Total | 100 | |